Corrigan KL, et al. - Researchers analyzed studies related to screening disparities for non-acquired immunodeficiency syndrome-defining malignancies (NADMs) among people with the human immunodeficiency virus (PWHIV). These studies were identified from PubMed, Cochrane, EMBASE, and ClinicalTrials.gov databases searched from January 1, 1996 through April 10, 2018. Any study performed in a high-income country that compared screening for NADMs by HIV status was eligible for inclusion. The analysis included only nine studies out of overall 613 unique studies identified through the search. Breast cancer screening, colorectal cancer screening, and prostate cancer screening were addressed in 3 studies, 4 studies, and 2 studies, respectively. The available evidence did not uniformly corroborate that PWHIV are less likely to receive cancer screening. They found an association of social determinants of health (insurance status, access to health care, education, income level), with the receipt of appropriate cancer screening. Improved cancer screening in PWHIV require addressing these barriers.